An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

Clinical trial NCT05123365 · RECRUITING

Trial details

NCT number: NCT05123365
Sponsor: University of California, Irvine
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm MPN Essential Thrombocythemia Polycythemia Vera Myelofibrosis

Start date: 2022-01-03
Primary completion: 2026-11-15
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.